
Thang N.H.
271
Coauthors
8
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2016 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Medicina interna | 6 |
Neurología | 5 |
Medicamento | 4 |
Trazado | 3 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Enfermedades | 6 |
Fisiología humana | 3 |
Ginecología, obstetricia, pediatría, geriatría | 3 |
Medicina y salud | 3 |
Farmacología y terapéutica | 3 |
Medicina forense; incidencia de enfermedades | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 8 |
Google Scholar | 0 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Octavio Marques Pontes-Neto | 8 |
Martins S.O. | 8 |
Wang J.G. | 7 |
Chalmers J. | 7 |
Robinson T.G. | 7 |
Arima H. | 7 |
Wang X. | 6 |
Olavarria V.V. | 6 |
Lavados P.M. | 6 |
Sharma V.K. | 6 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial
ArticleAbstract: Background: Early intensive blood pressure (BP) lowering remains the most promising treatment for acPalabras claves:Care bundle, Clinical trial, Intracerebral Hemorrhage, management, Stepped-wedge cluster-randomized trial, strokeAutores:Abanto C., Anderson C.S., Arauz-Gongora A., Billot L., Chen X., Hu X., Li Q., Ma L., Octavio Marques Pontes-Neto, Ouyang M., Pandian J.D., Silva A.d., Song L., Thang N.H., Venturelli P.M., Wahab K.W., Wasay M., You C.Fuentes:scopusInteraction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study
ArticleAbstract: Objective: To determine the extent to which the effects of intensive blood pressure (BP) lowering arPalabras claves:acute ischemic stroke, Blood pressure lowering, Hypertension, Intracerebral Hemorrhage, thrombolysisAutores:Arima H., Chalmers J., Delcourt C., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Robinson T.G., S Anderson C., Sandset E.C., Sharma V.K., Song L., Sun L., Thang N.H., Wang J.G., Wang X., Yang J.Fuentes:scopusLipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial
ArticleAbstract: Background: Debate exists as to whether statin pretreatment confers an increased risk of 90-day mortPalabras claves:Acute stroke outcome, Intracranial haemorrhage, Lipid-lowering therapy, OR, RISK FACTORS, statins, strokeAutores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Martins S.O., Minhas J.S., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusLow-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial
ArticleAbstract: IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the stPalabras claves:Autores:Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Li Q., Lindley R.I., Martins S.O., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Thang N.H., Wang J.G., Wang X., Woodward M.Fuentes:scopusTriple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress
ArticleAbstract: Background: Patients who suffer intracerebral hemorrhage (ICH) are at very high risk of recurrent ICPalabras claves:Blood pressure lowering, Clinical trial, Hypertension, Intracerebral Hemorrhage, OutcomesAutores:Anderson C.S., Arima H., Billot L., Chalmers J., Chen C., Chow C.K., De Silva H.A., Fisher U., Freed R., Kherkheulidze T., Klijn C.J.M., Lee T.H., Lindley R.I., MacMahon S., Martins S.O., Naismith S., Octavio Marques Pontes-Neto, Robinson T.G., Rodgers A., Salman R.A.S., Schreuder F.H., Senanayake B., Song L., Thang N.H., Wahab K.W., Wang J.G., Woodward M., Zaidi W.A.W.Fuentes:scopus